Q2 2026 Embla Medical hf Earnings Call Transcript

Jul 21, 2026 / 07:00 AM GMT

Transcript

Key Points

Positve

Embla Medical hf (FRA:5IQ) reported strong organic growth of 6% and a total sales increase of 11% in Q2 2026.
The prosthetics and neuroorthotics segments experienced double-digit growth, driven by strong execution and new product launches.
The company achieved a robust EBITDA margin of 22%, supported by strong performance in key segments and a $3 million U.S. tariff refund.
Net profit increased by 39%, attributed to strong operating results and favorable financial expense movements.
Embla Medical hf completed a $10 million share buyback program and initiated a new program of similar size, reflecting confidence in its financial position.

Negative

Sales in the patient care segment declined by 2% in Q2, with underperformance in Europe, particularly in Sweden and France.
The company narrowed its full-year organic sales growth guidance from 5%-8% to 5%-7%, indicating potential challenges in meeting higher growth expectations.
Despite progress, the patient care business has not yet returned to expected growth levels, with ongoing restructuring and integration challenges.
The bracing and supports segment grew only modestly at 1%, facing tough competition and changing market dynamics in EMEA.
The anticipated benefits from U.S. Medicare coverage expansion and new product launches are yet to fully materialize, impacting growth projections.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EMBLA.CO - Embla Medical hf
Q2 2026 Embla Medical hf Earnings Call
Jul 21, 2026 / 07:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
At this time, I would like to welcome everyone to this Emblem Medical Q2 2026 conference call.

Today's call is being recorded.

If you have any objections, please disconnect at this time.

All participants will be on listen-only mode throughout the presentation and afterwards there will be a question-and-answer session. I would now like to introduce President and CEO Sven Silverson and CFO Anna Sven Statia. Sven, over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you very much.

-----------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.